Sotos syndrome describes a childhood overgrowth disorder that is remarkable for excessive growth, distinguished facial features, and learning disabilities [1] [2]. Additionally, neonates may present with feeding difficulties, hypotonia, hypoglycemia, and jaundice [3]. Most cases result from NSD1 mutations, of which the majority are sporadic while some are noted to be of autosomal dominant inheritance [1] [4]. Beckwith-Wiedeman syndrome and Fragile X syndrome are among the differential diagnoses [1].

Neonates with this overgrowth condition are above average in terms of their weight, length, and occipitofrontal circumference (OFC) [3]. There is a significant growth in the child's first 12 months, which eventually becomes stable [1]. At pubertal age, the growth is appropriate and eventually results in an adult height that falls in the upper range of the normal curve [5]. The OFC remains between 98th and 99.6th percentile throughout the affected individual's life [6]. Moreover, advanced bone age is observed in most patients [1].

Craniofacial dysmorphia in infancy is striking for a prominent forehead. In childhood, the facies are characterized by an elongated head, macrodolichocephaly, frontal bossing, hypertelorism, downward slanting palpebral fissures, pointed jaw, and a highly arched palate [1] [6]. These features are less apparent in adulthood although they still have a prominent jaw.

Individuals with Sotos syndrome also exhibit a developmental delay in motor and speech skills and experience a lag in milestones [1]. Additionally, they may demonstrate behavioral problems such as attention deficit hyperactivity disorder (ADHD) and others [7].

Other manifestations that may be observed in these patients include anomalies of the heart (septal defects) and genitourinary system [1] [2] [8]. Furthermore, affected children may also manifest with brisk deep tendon reflexes, scoliosis, and seizures [1] [2] [6].

Neonates and children presenting with the abovementioned features should undergo a workup that includes a physical exam and the appropriate studies.

Experts recommend that NSD1 gene testing should be the initial test [2]. Confirmatory studies such as fluorescence in situ hybridization (FISH) or multiplex ligation-dependent probe amplification (MLPA) are used for identification of microdeletions [1]. Additionally, DNA sequencing is helpful for the detection of mutations.

Prenatal assessment can be offered to affected parents. Testing can be performed on samples derived from chorionic villus sampling (CVS) or amniocentesis.

On bone radiography, most patients will have advanced bone age although this is not a specific test as some patients will have appropriate bone age or delayed growth [6] [9].

Magnetic resonance imaging (MRI) and computed tomography (CT) scanning of the brain may reveal findings such as ventriculomegaly or abnormalities in the trigone and occipital horns [7] [10] [11]. However, these and other anomalies are not specific [11].

There is no cure for Sotos Syndrome, and treatment focuses on managing symptoms and improving quality of life. A multidisciplinary approach is often required, involving pediatricians, geneticists, neurologists, and other specialists. Early intervention programs, including physical, occupational, and speech therapy, can help address developmental delays. Behavioral therapy may be beneficial for managing ADHD or ASD symptoms. Regular monitoring and treatment of associated medical conditions, such as scoliosis or seizures, are also important.

The prognosis for individuals with Sotos Syndrome varies depending on the severity of symptoms and associated conditions. While physical growth tends to normalize in adulthood, developmental and learning challenges may persist. With appropriate support and interventions, many individuals can lead fulfilling lives. Lifespan is generally not affected, although complications from associated medical conditions may impact overall health.

Sotos Syndrome is primarily caused by mutations in the NSD1 gene, which is located on chromosome 5. This gene is responsible for producing a protein that regulates growth and development. Most cases of Sotos Syndrome occur sporadically, meaning they are not inherited from parents. However, in rare instances, the condition can be inherited in an autosomal dominant pattern, where a single copy of the mutated gene is sufficient to cause the disorder.

Sotos Syndrome is a rare condition, with an estimated prevalence of 1 in 10,000 to 1 in 14,000 live births. It affects both males and females equally and occurs across all ethnic groups. Due to its rarity and the variability of symptoms, Sotos Syndrome may be underdiagnosed or misdiagnosed as other growth or developmental disorders.

The pathophysiology of Sotos Syndrome is linked to disruptions in the NSD1 gene, which encodes a protein involved in chromatin modification and gene expression regulation. Mutations in this gene lead to abnormal growth and development, resulting in the characteristic features of the syndrome. The exact mechanisms by which NSD1 mutations cause the diverse symptoms of Sotos Syndrome are not fully understood, but they likely involve complex interactions between genetic and environmental factors.

Currently, there are no known methods to prevent Sotos Syndrome, as it is primarily caused by spontaneous genetic mutations. Genetic counseling may be beneficial for families with a history of the condition, especially in cases where the syndrome is inherited. Prenatal testing and early diagnosis can help prepare families for the management and care of affected individuals.

Sotos Syndrome is a rare genetic disorder characterized by excessive growth, distinctive facial features, and developmental delays. It is caused by mutations in the NSD1 gene and typically occurs sporadically. Diagnosis involves clinical evaluation and genetic testing, while treatment focuses on managing symptoms and associated conditions. With appropriate support, individuals with Sotos Syndrome can lead fulfilling lives, although developmental challenges may persist.

For patients and families affected by Sotos Syndrome, understanding the condition is crucial for effective management. Sotos Syndrome is a genetic disorder that leads to rapid growth and developmental delays. While there is no cure, early intervention and a multidisciplinary approach can help address symptoms and improve quality of life. Support from healthcare professionals, educators, and support groups can provide valuable resources and guidance for navigating the challenges associated with the syndrome.

1. Baujat G, Cormier-Daire V. Sotos syndrome. Orphanet Journal of Rare Diseases. 2007;2:36.
2. Tatton-Brown K, Rahman N. Sotos syndrome. Eur J Hum Genet. 2007;15(3):264-271.
3. Cole TRP, Hughes HE. Sotos syndrome: a study of the diagnostic criteria and natural history. J Med Genet. 1994;31(1):20–32.
4. Winship I. Sotos syndrome – autosomal dominance inheritance substantiated. Clin Genet. 1985;28(3):243–246.
5. Agwu JC, Shaw NJ, Kirk J, et al. Growth in Sotos syndrome. Arch Dis Child. 1999;80(4):339–342.
6. Tatton-Brown K, Douglas J, Coleman K, et al. Childhood Overgrowth Collaboration Genotype-phenotype associations in Sotos syndrome: an analysis of 266 individuals with NSD1 aberrations. Am J Hum Genet. 2005;77(2):193–204.
7. Cohen MM. Mental deficiency, alterations in performance, and CNS abnormalities in overgrowth syndromes. Am J Med Genet. 2003;117C(1):49–56.
8. Cole TRP. Congenital urological anomalies in Sotos syndrome. Br J Urol. 1996;78(1):156.
9. Tatton-Brown K, Rahman N. Clinical features of NSD1-positive Sotos syndrome. Clin Dysmorphol. 2004;13(4):199–204.
10. Aoki N, Oikawa A, Sakai T. Serial neuroimaging findings in Sotos syndrome. Am J Med Genet. Neurol Res. 1998;20(2):149-152.

11. Shaefer GB, Bodensteiner JB, Buehler BA, Lin A, Cole TR. The neuroimaging findings in Sotos syndrome. Am J Med Genet. 1997;68(4):571–576.